← Back to Screener
LeMaitre Vascular, Inc. (LMAT)
Price$91.42
Value ScoreD
Growth ScoreB
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-3.84%
Price vs S&P 500 (4W)-20.49%
VGM Score51.69
Market Capitalization$2.14B
P/E Ratio (Annual)37.10x
Indicated Dividend Yield (Annual)1.06%
All Metrics
P/CF (Annual)26.36x
Book Value / Share (Quarterly)$17.80
P/TBV (Annual)5.10x
Indicated Dividend (Annual)$1.00
Revenue Growth (3Y)15.57%
Cash Flow / Share (Quarterly)$3.46
Payout Ratio (TTM)30.93%
Price vs S&P 500 (YTD)5.77%
Gross Margin (TTM)72.39%
Net Profit Margin (TTM)24.35%
EPS (TTM)$2.67
10-Day Avg Trading Volume0.31M
EPS Excl Extra (TTM)$2.67
Revenue Growth (5Y)14.04%
EPS (Annual)$2.52
Dividend / Share (Annual)$0.80
ROI (Annual)10.27%
Gross Margin (Annual)71.53%
Net Profit Margin (5Y Avg)17.78%
Cash / Share (Quarterly)$16.07
P/E Basic Excl Extra (TTM)34.32x
Revenue Growth QoQ (YoY)11.16%
EPS Growth (5Y)19.48%
P/E Normalized (Annual)37.10x
ROA (Last FY)9.38%
Revenue Growth TTM (YoY)13.27%
EBITD / Share (TTM)$3.37
ROE (5Y Avg)11.22%
Operating Margin (TTM)28.51%
Cash Flow / Share (Annual)$3.27
P/B Ratio5.27x
P/B Ratio (Quarterly)6.13x
Net Income / Employee (Annual)$89,400
EV / Revenue (TTM)8.91x
Net Interest Coverage (TTM)17.33x
ROA (TTM)10.31%
EPS Growth QoQ (YoY)41.57%
EV / EBITDA (TTM)29.02x
EPS Incl Extra (Annual)$2.52
Current Ratio (Annual)12.89x
Quick Ratio (Quarterly)12.08x
3-Month Avg Trading Volume0.23M
52-Week Price Return16.75%
EV / Free Cash Flow (Annual)30.67x
P/E Incl Extra (TTM)34.32x
Revenue / Employee (TTM)$396,700
Tangible BV / Share (Quarterly)$16.41
P/S Ratio (Annual)8.58x
Asset Turnover (Annual)0.41x
52-Week High$118.01
Operating Margin (5Y Avg)22.02%
EPS Excl Extra (Annual)$2.52
CapEx CAGR (5Y)17.88%
Tangible BV CAGR (5Y)25.95%
26-Week Price Return12.09%
Quick Ratio (Annual)10.81x
13-Week Price Return-16.75%
Total Debt / Equity (Annual)0.43x
Current Ratio (Quarterly)14.32x
Enterprise Value$2.28B
Revenue / Share Growth (5Y)11.52%
Asset Turnover (TTM)0.42x
Book Value / Share Growth (5Y)15.47%
Revenue / Employee (Annual)$386,400
Inventory Turnover (Annual)1.05x
Pretax Margin (Annual)30.12%
Cash / Share (Annual)$15.77
3-Month Return Std Dev57.86%
Gross Margin (5Y Avg)67.27%
Net Income / Employee (TTM)$96,600
EBITDA CAGR (5Y)16.83%
EBITDA Interim CAGR (5Y)15.05%
ROE (Last FY)14.67%
Net Interest Coverage (Annual)18.10x
EPS Basic Excl Extra (Annual)$2.52
P/FCF (TTM)27.07x
Receivables Turnover (TTM)7.23x
EV / Free Cash Flow (TTM)28.86x
Total Debt / Equity (Quarterly)0.42x
EPS Incl Extra (TTM)$2.67
Receivables Turnover (Annual)7.84x
ROI (TTM)11.26%
Dividend Growth Rate (5Y)16.13%
P/S Ratio (TTM)8.36x
Pretax Margin (5Y Avg)23.12%
Revenue / Share (Annual)$10.89
Tangible BV / Share (Annual)$15.83
Forward P/E30.49x
Free OCF CAGR (5Y)18.54%
Price vs S&P 500 (52W)-11.46%
P/E Ratio (TTM)34.32x
EPS Growth TTM (YoY)35.22%
Year-to-Date Return16.71%
5-Day Price Return-3.17%
EPS Normalized (Annual)$2.52
ROA (5Y Avg)8.37%
Net Profit Margin (Annual)23.13%
Month-to-Date Return-13.76%
Cash Flow / Share (TTM)$1.64
EBITD / Share (Annual)$3.21
EPS Growth (3Y)39.48%
Operating Margin (Annual)27.21%
LT Debt / Equity (Annual)0.43x
P/CF (TTM)24.53x
ROI (5Y Avg)9.47%
P/E Excl Extra (TTM)34.32x
LT Debt / Equity (Quarterly)0.42x
EPS Basic Excl Extra (TTM)$2.67
P/TBV (Quarterly)6.65x
Payout Ratio (Annual)31.37%
P/B Ratio (Annual)4.68x
Dividend / Share (TTM)$0.85
Inventory Turnover (TTM)1.04x
Pretax Margin (TTM)31.46%
Book Value / Share (Annual)$17.28
Price vs S&P 500 (13W)-26.49%
Net Margin Growth (5Y)7.15%
Dividend Yield (TTM)0.90%
Beta0.53x
P/FCF (Annual)28.76x
Revenue / Share (TTM)$11.13
ROE (TTM)16.19%
52-Week Low$79.01
vGradeD
gGradeB
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.68est. 0.67
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.94
3.94
4.00
4.00
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
LMATLeMaitre Vascular, Inc. | D | B | C | $91.42 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
LeMaitre Vascular manufactures and distributes medical devices for treating peripheral vascular disease during open surgery, with primary revenue from lower extremity and carotid product lines. Its portfolio includes angioscopes, balloon catheters, vascular grafts, vessel closure systems, and related surgical devices. The company also processes and cryopreserves human tissues for implantation.